Showing 1 - 9 results of 9 for search 'Kunwei Shen', query time: 0.02s Refine Results
  1. 1
    Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohort

    Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohort by Shuai Li, Xiaosong Chen, Kunwei Shen

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.

    The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. by Yan Mao, Qing Qu, Yuzi Zhang, Junjun Liu, Xiaosong Chen, Kunwei Shen

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer

    Carboplatin-resistance-related DNA damage repair prognostic gene signature and its association with immune infiltration in breast cancer by Shuwen Dong, Anqi Li, Ruixin Pan, Jin Hong, Zheng Wang, Kunwei Shen

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.

    The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis. by Yan Mao, Qing Qu, Xiaosong Chen, Ou Huang, Jiayi Wu, Kunwei Shen

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A pyrimidine metabolism-related gene signature for prognosis prediction and immune microenvironment description of breast cancer

    A pyrimidine metabolism-related gene signature for prognosis prediction and immune microenvironment description of breast cancer by Han Wang, Ziling Zhou, Hanyi Zhong, Shoutang Wang, Kunwei Shen, Renhong Huang, Ruo Wang, Zheng Wang

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer

    Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer by Cuiyan Yang, Haoyu Wang, Yiwei Tong, Zheng Wang, Xi Sun, Anqi Li, Yujie Lu, Mengyuan Han, Siji Zhu, Lei Dong, Kunwei Shen, Xiaosong Chen

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Development and validation of a postoperative prognostic model for hormone receptor positive early stage breast cancer recurrence

    Development and validation of a postoperative prognostic model for hormone receptor positive early stage breast cancer recurrence by Ruixin Pan, Haoting Shi, Yiqing Shen, Xue Wang, Shi Zhao, Nan Zhang, Xueyan Zhang, Shuwen Dong, Chao Hu, Jiayi Wu, Weimin Chai, Xiaosong Chen, Kunwei Shen

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Targeting Reticulin 4 (RTN4) Within Small Extracellular Vesicles Combats Metastasis and Reinforces Immunotherapy in Triple‐Negative Breast Cancer

    Targeting Reticulin 4 (RTN4) Within Small Extracellular Vesicles Combats Metastasis and Reinforces Immunotherapy in Triple‐Negative Breast Cancer by Han Wang, Renhong Huang, Lei Luo, Ruo Wang, Ziling Zhou, Jin Hong, Jiayi Wu, Ou Huang, Jianrong He, Weiguo Chen, Yafen Li, Xiaosong Chen, Yang Wang, Zheng Wang, Kunwei Shen

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study

    Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the pha... by Qingyuan Zhang, Kunwei Shen, Chuan-gui Song, Quchang Ouyang, Zhenzhen Liu, Qiang Liu, Jifeng Feng, Joanne W. Y. Chiu, Jinhai Tang, Zefei Jiang, Ling-Ming Tseng, Xiaojia Wang, Liu Yang, Chenxi Qian, Zhimin Shao

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: